- Report
- October 2025
- 144 Pages
Global
From €3561EUR$3,999USD£3,105GBP
- Report
- March 2026
- 150 Pages
Global
From €3339EUR$3,750USD£2,912GBP
- Report
- November 2025
- 150 Pages
Global
From €3339EUR$3,750USD£2,912GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,166GBP
- Report
- June 2025
- 400 Pages
Global
From €4407EUR$4,949USD£3,843GBP
- Report
- January 2026
- 286 Pages
Global
From €2226EUR$2,500USD£1,941GBP
- Report
- June 2025
- 138 Pages
Global
From €3518EUR$3,950USD£3,067GBP
- Report
- February 2026
- 144 Pages
Global
From €3518EUR$3,950USD£3,067GBP
- Report
- January 2026
- 128 Pages
Global
From €3518EUR$3,950USD£3,067GBP
- Report
- August 2025
- 260 Pages
Global
From €4448EUR$4,995USD£3,879GBP
- Report
- November 2025
- 145 Pages
Global
From €3518EUR$3,950USD£3,067GBP
- Report
- December 2025
- 150 Pages
Global
From €4319EUR$4,850USD£3,766GBP
- Report
- October 2025
- 150 Pages
Global
From €4319EUR$4,850USD£3,766GBP
- Report
- July 2025
- 150 Pages
Global
From €4319EUR$4,850USD£3,766GBP
- Report
- February 2026
- 160 Pages
Global
From €2957EUR$3,320USD£2,578GBP
€3696EUR$4,150USD£3,223GBP
- Report
- January 2026
- 160 Pages
Global
From €2990EUR$3,358USD£2,608GBP
€3518EUR$3,950USD£3,067GBP
- Report
- January 2026
- 160 Pages
Global
From €2990EUR$3,358USD£2,608GBP
€3518EUR$3,950USD£3,067GBP
- Report
- November 2025
- 160 Pages
Global
From €2990EUR$3,358USD£2,607GBP
€3518EUR$3,950USD£3,067GBP
- Report
- November 2025
- 160 Pages
Global
From €2990EUR$3,358USD£2,607GBP
€3518EUR$3,950USD£3,067GBP
- Report
- October 2025
- 160 Pages
Global
From €2990EUR$3,358USD£2,607GBP
€3518EUR$3,950USD£3,067GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more